Liquidia (LQDA) Assets Average (2021 - 2026)
Liquidia (LQDA) recorded quarterly Assets Average of $364.7 million in Q1 2026, up 20.79% quarter-over-quarter from $302.0 million in Q4 2025, and up 59.36% on a YoY basis from $228.9 million in Q1 2025.
Liquidia (LQDA) Assets Average (2021 - 2026) Analysis & Trends
Liquidia's Assets Average history runs 6 years deep, the most recent figure standing at $364.7 million for Q1 2026.
- In Q1 2026, Assets Average rose 59.36% year-over-year to $364.7 million; the TTM figure through Mar 2026 stood at $364.7 million (up 59.36% YoY), while the FY2025 annual figure was $279.1 million, up 60.12% from the prior year.
- Assets Average was $364.7 million for Q1 2026 at Liquidia, up from $302.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $364.7 million in Q1 2026 to a low of $93.6 million in Q1 2022.
- Historically, Assets Average has averaged $186.4 million across 5 years, with a median of $157.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Assets Average decreased 14.14% in 2023, then surged 110.11% in 2024.
- A 5-year view of Assets Average shows it stood at $130.9 million in 2022, then declined by 12.15% to $115.0 million in 2023, then soared by 110.11% to $241.6 million in 2024, then gained by 24.98% to $302.0 million in 2025, then gained by 20.79% to $364.7 million in 2026.
- The last three Assets Average figures came in at $364.7 million (Q1 2026), $302.0 million (Q4 2025), and $266.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 2.29 Bn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 2.21 Bn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 364.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364.73 Mn |
| Dec 31, 2025 | 301.96 Mn |
| Sep 30, 2025 | 266.70 Mn |
| Jun 30, 2025 | 242.42 Mn |
| Mar 31, 2025 | 228.87 Mn |
| Dec 31, 2024 | 241.60 Mn |
| Sep 30, 2024 | 215.12 Mn |
| Jun 30, 2024 | 187.24 Mn |
| Mar 31, 2024 | 157.72 Mn |
| Dec 31, 2023 | 114.99 Mn |
| Sep 30, 2023 | 116.62 Mn |
| Jun 30, 2023 | 125.26 Mn |
| Mar 31, 2023 | 129.06 Mn |
| Dec 31, 2022 | 130.88 Mn |
| Sep 30, 2022 | 135.83 Mn |
| Jun 30, 2022 | 116.30 Mn |
| Mar 31, 2022 | 93.63 Mn |
| Dec 31, 2021 | 97.01 Mn |
| Sep 30, 2021 | 102.34 Mn |
| Jun 30, 2021 | 96.42 Mn |